Malcolm S. Taub is Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have made 14 open-market trades across 2 companies since 2009, most recently 2021-12-15.
CIK 0001305117
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCLI | SELL | 2015-12-14 | 2015-12-16 | $2.60 | $109K | -32.9% | -27.3% | -5.2% |
| BCLI | SELL | 2015-12-10 | 2015-12-14 | $2.73 | $37K | -32.9% | -32.9% | -7.3% |
| BCLI | SELL | 2011-07-08 | 2011-07-25 | $0.46 | $46K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2011-06-06 | 2011-06-08 | $0.28 | $9K | -32.9% | +3.1% | +3.1% |
| BCLI] | SELL | 2011-05-17 | 2011-05-19 | $0.30 | $21K | N/A | N/A | N/A |
| BCLI | SELL | 2011-04-12 | 2011-04-14 | $0.30 | $50K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2011-04-07 | 2011-04-11 | $0.30 | $2K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2011-04-04 | 2011-04-06 | $0.30 | $31K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2011-03-31 | 2011-04-04 | $0.30 | $8K | -32.9% | +3.1% | +3.1% |
| BCLI] | SELL | 2011-03-22 | 2011-03-24 | $0.30 | $13K | N/A | N/A | N/A |
| BCLI] | SELL | 2011-03-14 | 2011-03-16 | $0.31 | $13K | N/A | N/A | N/A |
| BCLI | SELL | 2011-03-10 | 2011-03-14 | $0.31 | $16K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2011-03-08 | 2011-03-10 | $0.32 | $42K | -32.9% | +3.1% | +3.1% |
| BCLI | SELL | 2009-09-14 | 2010-04-30 | $0.25 | $146K | -32.9% | +3.1% | +3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.